Argenx
ARGX
#791
Rank
$22.29 B
Marketcap
$400.34
Share price
-0.59%
Change (1 day)
26.12%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: $22.29 Billion

As of June 2023 Argenx has a market cap of $22.29 Billion. This makes Argenx the world's 791th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2023

End of year Market Cap

Year Market cap Change
2023$22.29 B6.35%
2022$20.95 B13.96%
2021$18.39 B31.15%
2020$14.02 B103.85%
2019$6.87 B96.18%
2018$3.50 B74.88%
2017$2.00 B
2014$0.14 B

End of Day market cap according to different sources

On Jun 6th, 2023 the market cap of Argenx was reported to be:

$22.29 Billion
by Yahoo Finance
$22.29 Billion
by CompaniesMarketCap
$22.29 Billion
by Nasdaq
$22.31 Billion
by Iex Cloud